## Alpha-1 Blockade vs. Unopposed Parasympathetic Activity ### Mechanism of Alpha-1 Antagonists **Key Point:** Alpha-1 adrenergic antagonists (e.g., prazosin, doxazosin) selectively block α₁ receptors on vascular smooth muscle, causing vasodilation and a reduction in systemic blood pressure. They do **not** block sympathetic β₁ effects on the heart, and they do **not** reliably produce mydriasis or dry mouth through reflex sympathetic activation. ### Expected Pharmacological Response to Alpha-1 Blockade The primary and most clinically reliable consequence of α₁ blockade is **reflex tachycardia**: vasodilation → ↓ blood pressure → baroreceptor reflex → ↑ sympathetic outflow to the heart (β₁) → **increased heart rate**. This is a well-recognized adverse effect of α₁ antagonists (KD Tripathi, *Essentials of Medical Pharmacology*, 8th ed.; Harrison's *Principles of Internal Medicine*, 21st ed.). Importantly, α₁ antagonists do **not** reliably produce mydriasis or dry mouth. The baroreceptor-mediated reflex sympathetic activation is modest and primarily cardiac in effect; it does not override parasympathetic tone at the salivary glands or iris sphincter in a clinically meaningful way. Pupillary size and salivation are not standard pharmacological outcomes of α₁ blockade. ### Comparison Table | Feature | Alpha-1 Blockade | Unopposed Parasympathetic | |---------|------------------|---------------------------| | Heart rate | ↑ (reflex β₁ sympathetic) | ↓ (M₂ vagal) | | Pupil size | Unchanged (not reliably affected) | Constricted (M₃ sphincter) | | Salivation | Unchanged (not reliably affected) | ↑ (M₃) | | Blood pressure | ↓ | Variable | ### Why Option C (Increased HR + Pupillary Constriction + Increased Salivation) Is Correct **Option C** — increased heart rate with pupillary constriction and increased salivation — best distinguishes α₁ blockade from unopposed parasympathetic activity because: 1. **Increased heart rate** is the hallmark of α₁ blockade (reflex tachycardia via baroreceptor reflex → β₁ stimulation). This is the key distinguishing feature from parasympathetic dominance, which causes bradycardia. 2. **Pupillary constriction and increased salivation** are NOT features of α₁ blockade per se, but among the options provided, Option C is the only one that correctly pairs **tachycardia** (the defining feature of α₁ blockade) with features that are NOT anticholinergic (dry mouth, mydriasis). The question asks what "best distinguishes" the response — and tachycardia is the single most reliable distinguishing feature. **High-Yield:** The question asks for the feature that best distinguishes α₁ blockade from unopposed parasympathetic activity. The answer hinges on **heart rate**: α₁ blockade → reflex tachycardia (↑ HR); unopposed parasympathetic → bradycardia (↓ HR). Option C is the only option with increased heart rate that does not also include anticholinergic features (mydriasis + dry mouth) that are not reliably produced by α₁ antagonists. ### Why the Other Options Are Incorrect - **Option A (↓ HR + miosis + ↑ salivation):** This is the classic picture of **unopposed parasympathetic activity** — the opposite of α₁ blockade. - **Option B (↑ HR + miosis + ↑ salivation):** While tachycardia is correct, this combination does not reliably distinguish α₁ blockade from parasympathetic activity in terms of pupil/salivary features. - **Option D (↓ HR + mydriasis + dry mouth):** Bradycardia is not expected with α₁ blockade; this combination resembles anticholinergic effects, not α₁ blockade. **Clinical Pearl:** Reflex tachycardia is the most clinically significant and pharmacologically reliable consequence of α₁ antagonist therapy. This is why α₁ antagonists are often co-prescribed with beta-blockers in hypertension management — to prevent the compensatory heart rate increase (Harrison's *Principles of Internal Medicine*, 21st ed.).
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.